当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Prateek Upadhyay, Prashant Ahlawat
The global health care burden of Chronic Obstructive Pulmonary Disease (COPD) is enormous. Patients who are battling COPD have a very poor quality of life and suffer physically, mentally, emotionally, socially, and spiritually. Many treatment modalities have been in practice for a long time, but have limitations. The consequence of disregard for quality of life has generated a lot of unmet needs for patients. These patients deserve a good quality of life and a timely institution of palliative care to maintain the continuum of care. This article aims to highlight novel modalities, preferably non invasive or minimally invasive, that can be used to alleviate the suffering of patients with COPD. Lung flute is slowly finding its way into routine clinical practice for palliation of patients with COPD. It has the potential to be used as effortlessly as a hand-held incentive spirometer that is used in hospitals day in and day out. Bronchoscopic Lung Volume Reduction or Valve Surgery, Targeted Lung Denervation therapy, Metered Cryospray in addition to research on Stem Cell therapy are novel measures with hopeful and promising results so far to improve the quality of life of COPD survivors.